Gintant, Gary
Sager, Philip T.
Stockbridge, Norman
Article History
First Online: 19 February 2016
Competing interests
: P.T.S. is a cardiac safety consultant (a member of the Data Safety and Monitoring Board, a member of the cardiovascular end-point committee, a consultant or an advisory board member) to Chemo, Milestone Pharmaceuticals, Medtronic, Cellceutix, Halozyme, NeuroVia, Trevi, S. K. Science, Viamet, Shin Nippon Biomedical Laboratories (SNBL), Biomedical Systems, iCardiac, Dart, Cancer Prevention, AbbVie, Heart Metabolics, Acadia, MyoKardia, Biogen, Theravance, Charles River, Acesion, Vivus and NDA Partners. Finally, P.T.S. is also a member of the Board of Directors of Anthera, Inc. He has no financial stake in any of the technologies discussed in the manuscript.